Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proline rich 13 pseudogene 5 (PRR13P5) is annotated as a pseudogene in human genome reference databases and does not encode a functional protein. Pseudogenes are DNA sequences similar to functional genes but are typically non-functional due to mutations or lack of regulatory elements. There is no evidence that PRR13P5 has a role as a receptor, enzyme, drug target, or biomarker. No disease associations or pharmacological interactions have been described in public biomedical sources[3][9]. PRR13P5 is a pseudogene, not a protein-coding gene or established drug target. No evidence supports a role for this locus as a receptor, enzyme, or other therapeutic target class. There are similarly named protein-coding genes, such as Proline rich 13 (PRR13)[6], but these are distinct and should not be confused with PRR13P5. As such, PRR13P5 is not a viable target for drug discovery or disease association studies, and its inclusion as a therapeutic or biological target would be considered incorrect or a data error[3][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proline rich 13 pseudogene 5 (PRR13P5).